Ibogaine is a naturally occurring plant alkaloid found in the root bark of a shrub called Tabernanthe Iboga that grows in the forests of West Africa. It is a potent psychoactive substance that has the unique property of significantly removing withdrawal symptoms and reducing cravings from substances that cause chemical dependence. It has a long history of being used traditionally as a ceremonial, medicinal and spiritual tool in West Africa. For the last 40 years, it has increasingly been used in western society as a unique therapy for detoxification from drugs and for other psychotherapeutic purposes.
Research and reports from those who have used it to assist in their recovery from addiction also suggest it is effective in initiating an intense and profound therapeutic experience that may provide deep personal insight and healing.
Project Iboga is dedicated to guiding Iboga research. Our primary goal is for ibogaine and 18-MC, an improved analog, to go though complete U.S. FDA approved clinical trials in order to gain approval as a conventional treatment option for drug detoxification. While there are many capable individuals and institutions working on Iboga research and commercialization there isn't a central entity, like a for-profit concern continuously pushing through administrative road-blocks. Due to the marginalization of drug addicts and the uninsured poor these substances are basically orphan drugs, even though there are literally millions who could benefit from Iboga treatments for their drug dependence.
We support the conduct of ethical research and the initiation of clinical trials to demonstrate its effectiveness as a potent healing modality and natural health product.